World's Best Scientists 2026 revealed!
Ramón García-Sanz

Ramón García-Sanz

D-Index & Metrics

Medicine

D-Index
90
Citations
30232
World Ranking
12195
National Ranking
172

Overview

Ramón García-Sanz is affiliated with the University of Salamanca in Spain. Their research is situated primarily within the field of Medicine, with a focused expertise in Hematology. The scientist has contributed extensively to subfields including Genetics, Pathology and Forensic Medicine, Oncology, and Immunology.

The research topics covered by Ramón García-Sanz center on various aspects of hematological diseases and treatments. Main topics include:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Protein Degradation and Inhibitors

Their publication record features numerous articles in prominent scientific journals. Frequent venues for publication consist of:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Hematological Oncology
  • HemaSphere
  • Blood Advances

Noteworthy recent papers include:

  • A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study (2020), published in Blood
  • COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) (2021), published in Journal of Hematology & Oncology
  • Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group (2021), published in The Lancet Oncology
  • A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma (2020), published in Blood
  • Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma (2020), published in Blood

Ramón García-Sanz has collaborated extensively with a core group of scientific co-authors. Frequent co-authors include:

  • Joaquin Martínez-López
  • Noemí Puig
  • María-Victoria Mateos
  • Carmen Chillón
  • Jesús F. San Miguel

Best Publications

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

    J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans

  • Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    J Flores-Montero;L Sanoja-Flores;B Paiva;N Puig

  • New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

    Ernesto Pérez-Persona;María-Belén Vidriales;Gema Mateo;Ramón García-Sanz

  • Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

    María-Victoria Mateos;Albert Oriol;Joaquín Martínez-López;Norma Gutiérrez

  • Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

    María-Victoria Mateos;María-Victoria Mateos;José-M. Hernández;José-M. Hernández;Miguel-T. Hernández;Miguel-T. Hernández;Norma-C. Gutiérrez;Norma-C. Gutiérrez

  • International prognostic scoring system for Waldenstrom macroglobulinemia

    Pierre Morel;Alain Duhamel;Paolo Gobbi;Meletios A. Dimopoulos

  • Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

    Joaquin Martinez-Lopez;Juan J. Lahuerta;François Pepin;Marcos González

  • Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic Characteristics

    R. Garcı́a-Sanz;A. Orfão;M. González;M.D. Tabernero

  • International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease

    Evangelos Terpos;Gareth Morgan;Meletios Athanasios Dimopoulos;Matthew T. Drake

  • Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

    Noopur Raje;Evangelos Terpos;Wolfgang Willenbacher;Kazuyuki Shimizu

  • International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

    Jens Hillengass;Saad Usmani;S Vincent Rajkumar;Brian G M Durie

  • A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.

    Constantine S. Tam;Stephen Opat;Shirley D'Sa;Wojciech Jurczak

  • A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia

    C Cobaleda;N Gutiérrez-Cianca;J Pérez-Losada;T Flores

  • Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.

    Maria E. Sarasquete;Ramon García-Sanz;Luis Marín;Miguel Alcoceba

  • Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

    Meletios A. Dimopoulos;Alessandra Tedeschi;Judith Trotman;Ramón García-Sanz

  • Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms.

    Brian A Walker;Christopher P Wardell;Lorenzo Melchor;Annamaria Brioli

  • Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop.

    Roger G. Owen;Robert A. Kyle;Marvin J. Stone;Andy C. Rawstron

  • Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

    M. Ocqueteau;A. Orfao;J. Almeida;J. Bladé

  • Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

    Ramón García‐Sanz;Silvia Montoto;Agustín Torrequebrada;Alfonso García De Coca

  • Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

    María-Victoria Mateos;Albert Oriol;Joaquín Martínez-López;Norma Gutiérrez

Frequent Co-Authors

Jesús F. San Miguel
Jesús F. San Miguel University of Navarra
Marcos González
Marcos González University of Salamanca
Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca
Juan José Lahuerta
Juan José Lahuerta Complutense University of Madrid
Joan Bladé
Joan Bladé University of Barcelona
Albert Oriol
Albert Oriol Autonomous University of Barcelona
Alberto Orfao
Alberto Orfao University of Salamanca
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
David Gonzalez
David Gonzalez University of California, San Diego
Steven P. Treon
Steven P. Treon Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a wide range of healthcare careers. For those interested in leadership or the business side of healthcare, a healthcare administration associate degree online can provide foundational skills for managing clinics or hospitals.

Nurses seeking better opportunities may consider adn to np programs online. These bridge programs are ideal for registered nurses with an associate degree, allowing them to advance to a nurse practitioner role more efficiently.

Interested in diet, wellness, or preventive care? Accredited online nutrition degree programs prepare students for roles in health education, food service management, or even community outreach.

For those aiming for high-level leadership, the best mha programs offer advanced, CAHME-accredited online degrees focused on healthcare administration and policy.

Whether your interests lie in direct patient care, management, or public health, these online degree options provide flexible pathways to diverse careers within the US healthcare system.

Best Scientists Citing Ramón García-Sanz

Trending Scientists